Signaling pathways
-
BA8893 LMTK3-IN-1Summary: LMTK3-IN-1 is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (=2.5 μM) and acts through the ubiquitin proteasome pathway to degrade LMTK3. - BA8894 EmzeltrectinibSummary: Emzeltrectinib is a potent tyrosine kinase inhibitor.
- BA8895 AdrixetinibSummary: Adrixetinib is a protein tyrosine kinase inhibitor.
- BA8896 c-Met-IN-15Summary: c-Met-IN-15 is a kinase inhibitor.
- BA8897 WRG-28Summary: WRG-28 is a selective, extracellularly acting mutational inhibitor.
- BA8898 VU6015929Summary: VU6015929 is a potent, selective, orally active inhibitor.
- BA8899 BAY-826Summary: BAY-826 is a selective and potent inhibitor.
- BA8900 DDR1-IN-6Summary: DDR1-IN-6 is a selective disk structural domain receptor family member 1 inhibitor.
- BA8901 DDR1-IN-4Summary: Effective and selective inhibitor of discopeptide structural domain receptor 1 autophosphorylation.
- BA8902 DDR1-IN-5Summary: DDR1-IN-5 is a selective disk structural domain receptor family member 1 inhibitor.